بعض محتويات هذا التطبيق غير متوفرة في الوقت الحالي.
إذا استمرت هذه الحالة ، يرجى الاتصال بنا علىتعليق وإتصال
1. (WO2003004470) CRYSTALLINE FORMS OF 'R-(R*,R*)!-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-'PHENYLAMINO)CARBONYL!-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)
أحدث البيانات الببلوغرافية المتوفرة لدى المكتب الدولي   

رقم النشر: WO/2003/004470 رقم الطلب الدولي: PCT/IB2002/001796
تاريخ النشر: 16.01.2003 تاريخ الإيداع الدولي: 21.05.2002
الفصل الثاني من الطلب المودع: 17.07.2002
التصنيف الدولي للبراءات:
C07D 207/34 (2006.01)
Description not available in lang ar
المودعون:
BYRN, Stephen, Robert [US/US]; US (UsOnly)
COATES, David, Andrew [US/US]; US (UsOnly)
GUSHURST, Karen, Sue [US/US]; US (UsOnly)
MORRISON, Henry, Grant, II [US/US]; US (UsOnly)
PARK, Aeri [KR/US]; US (UsOnly)
VLAHOVA, Petinka Ivanova [BG/US]; US (UsOnly)
LI, Zheng, Jane [US/US]; US (UsOnly)
KRZYZANIAK, Joseph, Francis [US/US]; US (UsOnly)
WARNER-LAMBERT COMPANY LLC [US/US]; 201 Tabor Road Morris Plains, NJ 07950, US (AE, AG, AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NE, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZM, ZW)
المخترعون:
BYRN, Stephen, Robert; US
COATES, David, Andrew; US
GUSHURST, Karen, Sue; US
MORRISON, Henry, Grant, II; US
PARK, Aeri; US
VLAHOVA, Petinka Ivanova; US
LI, Zheng, Jane; US
KRZYZANIAK, Joseph, Francis; US
الوكيل:
LUMB, J., Trevor; Pfizer Inc. 201 Tabor Road Morris Plains, NJ 07950, US
بيانات الأولوية:
60/302,04929.06.2001US
العنوان (EN) CRYSTALLINE FORMS OF 'R-(R*,R*)!-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-'PHENYLAMINO)CARBONYL!-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)
(FR) FORMES CRISTALLINES DE SEL HEMICALCIQUE D'ACIDE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIQUE (ATORVASTATINE)
الملخص:
(EN) Novel crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-$g(b), Δ;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt atorvastatin designated Form V, Form VI, Form VII, Form VIII, Form IX, Form X, Form XI, Form XII, Form XIII, Form XIV, Form XV, Form XVI, Form XVII, Form XVIII, and Form XIX are characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, and Alzheimer's disease.
(FR) L'invention concerne des nouvelles formes cristallines de sel hémicalcique d'acide [R-(R*,R*)]-2-(4-fluorophényl)-$g(b),$g(d)-dihydroxy-5-(1-méthyléthyl)-3-phényl-4-[(phénylamino)carbonyl]-1H-pyrrole-1-heptanoïque (atorvastatine), appelées Forme V, Forme VI, Forme VII, Forme VIII, Forme IX, Forme X, Forme XI, Forme XII, Forme XIII, Forme XIV, Forme XV, Forme XVI, Forme XVII, Forme XVIII et Forme XIX. Ces formes sont caractérisées par leur diffraction des rayons X sur poudre, leur NMR en phase solide et/ou leur spectroscopie Raman. L'invention concerne également des procédés de préparation et une composition pharmaceutique de ces formes, lesquelles sont utiles comme agents destinés à traiter l'hyperlipidémie, l'hypercholestérolémie, l'ostéoporose et la maladie d'Alzheimer.
الدول المعيّنة: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW
المنظمة الإقليمية الأفريقية للملكية الفكرية (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
مكتب البراءات الأوروبي الآسيوي (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
المكتب الأوروبي للبراءات (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
المنظمة الأفريقية للملكية الفكرية (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
لغة النشر: الإنكليزية (EN)
لغة الإيداع: الإنكليزية (EN)